Rescue of chemorefractory classical Hodgkin lymphoma with nivolumab and autologous stem-cell transplantation: Real-life experience

被引：0
|
作者：
Buccheri, Valeria [1 ,2 ]
Fatobene, Giancarlo [1 ,3 ]
Santos, Fernanda M. [2 ]
Velasques, Rodrigo D. [2 ]
Bellesso, Marcelo [2 ]
Atanazio, Marcelo J. [1 ,2 ]
Rocha, Vanderson [1 ,2 ,3 ]
机构：
[1] Univ Sao Paulo, Fac Med, Hosp Clin, Div Hematol, Sao Paulo, Brazil
[2] Inst Canc Estado Sao Paulo, Hematol Div, Sao Paulo, Brazil
[3] Hosp Sirio Libanes, Div Oncol, Sao Paulo, Brazil
来源：
HEMATOLOGICAL ONCOLOGY | 2021年 / 39卷 / 01期
关键词：
RESPONSE ASSESSMENT; MULTICOHORT; FAILURE;
D O I：
10.1002/hon.2796
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：134 / 136
页数：3
相关论文
共 50 条
  • [41] The role of autologous haematopoietic stem-cell transplantation in mantle cell lymphoma
    Chiappella, Annalisa
    Ladetto, Marco
    LANCET HAEMATOLOGY, 2021, 8 (09): : E617 - E619
  • [42] Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma
    Sirohi, B.
    Cunningham, D.
    Powles, R.
    Murphy, F.
    Arkenau, T.
    Norman, A.
    Oates, J.
    Wotherspoon, A.
    Horwich, A.
    ANNALS OF ONCOLOGY, 2008, 19 (07) : 1312 - 1319
  • [43] Should rituximab be used prior to autologous stem-cell transplantation for non-Hodgkin's lymphoma?
    Rodriguez, J
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (02): : 74 - 75
  • [44] AUTOLOGOUS STEM-CELL TRANSPLANTATION IN REFRACTORY OR RELAPSE HODGKIN'S LYMPHOMA: MONOCENTRIC STUDY OF 85 PATIENTS
    Devillier, R.
    Rey, J.
    Harbi, S.
    Benarous, L.
    Salinas, V.
    Coso, D.
    Ivanov, V.
    de Collela, J. M. Schiano
    Vey, N.
    Charbonnier, A.
    Ladaique, P.
    Chetaille, B.
    Gastaut, J. A.
    Chabannon, C.
    Blaise, D.
    Xerri, L.
    Stoppa, A. M.
    Bouabdallah, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 634 - 634
  • [45] Real-Life Experience of the Combination of Daratumumab, Bortezomib, Melphalan, and Prednisone (DVMP) in Patients with Newly Diagnosed Multiple Myeloma Ineligible for Autologous Stem-Cell Transplantation
    Domingo-Gonzalez, Amalia
    Alonso Fernandez, Rafael
    Jimenez, Ana
    De Soto Alvarez, Teresa
    Lerma, Ana
    Pradillo Fernandez, Virginia
    Benzo Callejo, Gonzalo
    Sanchez-Pina, Jose
    Landete, Elena
    Velasco, Alberto
    Menendez Cuevas, Marina
    Lopez Rinon, Monica Maria
    Ramirez Lopez, Andres
    Lopez Garcia, Alberto
    Blanchard, Maria-Jesus
    Askari, Elham
    BLOOD, 2023, 142
  • [46] BRENTUXIMAB VEDOTIN (BV) CONSOLIDATION AFTER AUTOLOGOUS STEM CELLS TRANSPLANTATION (ASCT) FOR RELAPSED/REFRACTORY (R/R) CLASSICAL HODGKIN LYMPHOMA (CHL): A REAL-LIFE EXPERIENCE BY FONDAZIONE ITALIANA LINFOMI (FIL)
    Massaro, F.
    Pavone, V.
    Stefani, P. M.
    Botto, B.
    Pulsoni, A.
    Patti, C.
    Cantonetti, M.
    Visentin, A.
    Scalzulli, P. R.
    Rossi, A.
    Galimberti, S.
    Cimminiello, M.
    Gini, G.
    Musso, M.
    Sorio, M.
    Arcari, A.
    Zilioli, V. R.
    Luppi, M.
    Mannina, D.
    Fabbri, A.
    Pietrantuono, G.
    Annibali, O.
    Tafuri, A.
    Prete, E.
    Mule, A.
    Barbolini, E.
    Marcheselli, L.
    Luminari, S.
    Merli, F.
    HAEMATOLOGICA, 2021, 106 (10) : 45 - 45
  • [47] Y90 Plus High Dose BEAM with Autologous Stem Cell Transplantation for Chemorefractory Non Hodgkin Lymphoma.
    Krishnan, Amrita
    Raubitschek, Andrew
    Palmer, Joycelynne
    Nademanee, Auayporn P.
    Kogut, N.
    Yamauchi, Dave
    Popplewell, Leslie
    Federico, Laura
    Simpson, Jennifer
    Tsai, Ni-Chun
    Forman, Stephen J.
    BLOOD, 2009, 114 (22) : 1329 - 1330
  • [48] Mobilization for Autologous Stem Cell Transplantation in Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma: A Single Institution Experience
    Haverkos, Bradley M.
    Geyer, Susan
    McBride, Ali
    Penza, Sam
    Devine, Steven M.
    Andritsos, Leslie A.
    Jaglowski, Samantha
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S111 - S112
  • [49] Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study
    De Filippi, Rosaria
    Marcacci, Gianpaolo
    Derenzini, Enrico
    Musso, Maurizio
    Donnarumma, Daniela
    Morelli, Emanuela
    Patti, Caterina
    Maraglino, Alessio Maria Edoardo
    Scalone, Renato
    Simeone, Luigia
    Becchimanzi, Cristina
    Mele, Sara
    Crisci, Stefania
    Morabito, Fortunato
    Pinto, Antonio
    CANCERS, 2022, 14 (23)
  • [50] RISK FACTORS IN AUTOLOGOUS STEM CELL TRANSPLANTATION IN HODGKIN LYMPHOMA : A SINGLE-CENTRE EXPERIENCE
    Milunovic, V.
    Patekar, M.
    Zatezalo, V.
    Radic-Kristo, D.
    Planinc-Peraica, A.
    Jaksic, B.
    Kolonic, S.
    HAEMATOLOGICA, 2013, 98 : 571 - 572
12345